Wegovy launches in Australia The manufacturer assured GPs supply planning has been its priority amid critical Ozempic shortages, but concerns remain over Wegovy’s availability.
Semaglutide supplies return to Australia ahead of schedule Limited quantities of the medication will be available from late next week, the TGA has said, but GPs have been asked to not prescribe it off-label.
‘The virus has evolved’: Fifth COVID dose available soon Adults will become eligible for a fifth dose from 20 February, supported by a new incentive for GPs attending aged care and disability facilities.
Concerns over growing misuse of Rikodeine cough medicine The addictive cough suppressant is popular among young people, more potent than codeine, and poses a serious risk of harm.
Mounjaro expanded to include weight management The TGA has approved tirzepatide for the treatment of overweight and obesity for those with comorbidities, via private prescription.
What does clutter do to your brain and body? An expert in organisational behaviour examines the effects disorganisation.
Shingrix to replace Zostavax on the National Immunisation Program The news has been welcomed by the Immunisation Coalition, but there are also concerns about eligibility restrictions.
What GPs need to know about the new COVID antivirals Both oral antiviral COVID-19 treatments are now available, with significant restrictions, on the PBS.
Concerns over growing misuse of Rikodeine cough medicine The addictive cough suppressant is popular among young people, more potent than codeine, and poses a serious risk of harm.
Semaglutide unavailable in Australia until April 2023 GPs have been told not to initiate any new patients on either semaglutide or dulaglutide, which will also only have ‘limited availability’.